Cavu Advisors, LLC - Insider Non-Derivative Transactions at Lantern Pharma Inc. (LTRN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 17, 2024, Cavu Advisors, LLC's relationship to Lantern Pharma Inc. (LTRN) is TenPercentOwner, and currently has 591,036 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LTRN insiders.
Data Source: SEC.
Cavu Advisors, LLC - Insider Non-Derivative Transactions of LTRN Common Stock
Cavu Advisors, LLC - Insider Non-Derivative Transactions at LTRN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 18, 2024 | Sell -- (Common Stock) | 5475 | 4.2 | 73646 |
| Jan 18, 2024 | X -- (Common Stock) | 7347 | 3.13 | 79121 |
| Jan 18, 2024 | Sell -- (Common Stock) | 12521 | 4.2 | 168417 |
| Jan 18, 2024 | X -- (Common Stock) | 16801 | 3.13 | 180938 |
| Jan 18, 2024 | Sell -- (Common Stock) | 40893 | 4.2 | 550143 |
| Jan 18, 2024 | X -- (Common Stock) | 54873 | 3.13 | 591036 |
| Nov 30, 2023 | Sell -- (Common Stock) | 53640 | 3.44 | 217553 |
| Nov 30, 2023 | Sell -- (Common Stock) | 91708 | 3.44 | 371950 |